4 ACIR Strategies for the Cosmetics and Pharmaceutical Sector

The cosmetics and pharmaceutical market in Central Asia is continuously growing. According to official data, the demand for European products has increased by 25% in the last five years, driven by the rising preference for higher quality standards and the expansion of the middle class in the region. This scenario presents a significant opportunity for companies looking to enter these emerging markets. ACIR Southern Europe has developed four key strategies to facilitate market entry and consolidation:

1. Supply of European Products We facilitate the import and distribution of European cosmetics and pharmaceutical products in Central Asia, ensuring compliance with international regulations and standards.

2. Trial Production and Re-export We implement trial production models in specialized European factories, optimizing costs and logistics before exporting to Central Asia.

3. Laboratory Establishment and Localized Production We support the establishment of laboratories and localized production in Central Asia, promoting technology transfer and production independence.

4. Hybrid Promotion and International Events We develop combined marketing strategies in Europe and Central Asia, including business missions, conferences, and networking platforms.

These strategies enable European companies to access an expanding market while minimizing risks and maximizing growth opportunities.